1. Home
  2. NKTR
  3. NKTR News

Latest Nektar Therapeutics (NKTR) News on January 22, 2025

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
NKTR

PR Newswire

12 days ago

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

NKTR

MT Newswires

14 days ago

B. Riley Starts Nektar Therapeutics With Buy Rating, $4 Price Target

Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media?
NKTR

Insider Monkey

15 days ago

Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media?

Institutional investors have a lot riding on Nektar Therapeutics (NASDAQ:NKTR) with 68% ownership
NKTR

Simply Wall St.

18 days ago

Institutional investors have a lot riding on Nektar Therapeutics (NASDAQ:NKTR) with 68% ownership

NKTR

MT Newswires

a month ago

HC Wainwright Initiates Nektar Therapeutics at Buy With $6.50 Price Target

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting
NKTR

PR Newswire

a month ago

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
NKTR

PR Newswire

2 months ago

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets
NKTR

Simply Wall St.

2 months ago

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations
NKTR

Simply Wall St.

2 months ago

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus
NKTR

Zacks

2 months ago

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook
NKTR

GuruFocus.com

2 months ago

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates
NKTR

Zacks

2 months ago

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates

NKTR

Associated Press Finance

2 months ago

Nektar: Q3 Earnings Snapshot

Nektar Therapeutics Reports Third Quarter 2024 Financial Results
NKTR

PR Newswire

2 months ago

Nektar Therapeutics Reports Third Quarter 2024 Financial Results

NKTR

MT Newswires

2 months ago

Nektar Therapeutics Says NKTR-255 Boosts Immune Recovery After Radiation Therapy

Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting
NKTR

PR Newswire

2 months ago

Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nektar Therapeutics to Participate in Upcoming Investor Conferences
NKTR

PR Newswire

2 months ago

Nektar Therapeutics to Participate in Upcoming Investor Conferences

Nektar Therapeutics to sell Alabama facility to Ampersand
NKTR

Pharmaceutical Technology

3 months ago

Nektar Therapeutics to sell Alabama facility to Ampersand

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
NKTR

Benzinga

3 months ago

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

NKTR

MT Newswires

3 months ago

Nektar Therapeutics Shares Rise After Deal to Sell Alabama Facility, PEGylation Business for $90 Million

Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama
NKTR

PR Newswire

3 months ago

Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
NKTR

PR Newswire

3 months ago

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
NKTR

PR Newswire

3 months ago

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

NKTR

MT Newswires

3 months ago

Nektar Therapeutics Up After Leukemia Candidate Found Beneficial in Early-Stage Study

Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
NKTR

PR Newswire

3 months ago

Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024
NKTR

PR Newswire

4 months ago

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
NKTR

Zacks

4 months ago

Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?

Nektar Management to Present at Upcoming Investor Conferences
NKTR

PR Newswire

5 months ago

Nektar Management to Present at Upcoming Investor Conferences

What Makes Nektar (NKTR) a New Buy Stock
NKTR

Zacks

5 months ago

What Makes Nektar (NKTR) a New Buy Stock

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NKTR

Simply Wall St.

5 months ago

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top
NKTR

Zacks

5 months ago

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
NKTR

Zacks

5 months ago

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

NKTR

Associated Press Finance

5 months ago

Nektar: Q2 Earnings Snapshot

Nektar Therapeutics Reports Second Quarter 2024 Financial Results
NKTR

PR Newswire

5 months ago

Nektar Therapeutics Reports Second Quarter 2024 Financial Results

Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets
NKTR

PR Newswire

6 months ago

Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets

Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week
NKTR

Simply Wall St.

6 months ago

Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week

Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
NKTR

PR Newswire

7 months ago

Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024

Italian energy company targets Britain for fleet of 20 mini-nukes
NKTR

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
NKTR

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
NKTR

Simply Wall St.

7 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
NKTR

Simply Wall St.

7 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
NKTR

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
NKTR

Simply Wall St.

7 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Seoul resumes loudspeaker propaganda against North
NKTR

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
NKTR

Simply Wall St.

7 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Nektar Therapeutics' (NASDAQ:NKTR) investors will be pleased with their stellar 130% return over the last year
NKTR

Simply Wall St.

8 months ago

Nektar Therapeutics' (NASDAQ:NKTR) investors will be pleased with their stellar 130% return over the last year

Nektar Management to Present at Upcoming Investor Conferences
NKTR

PR Newswire

8 months ago

Nektar Management to Present at Upcoming Investor Conferences

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
NKTR

Insider Monkey

8 months ago

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

NKTR

GuruFocus.com

8 months ago

Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
NKTR

Zacks

8 months ago

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

NKTR

Thomson Reuters StreetEvents

8 months ago

Q1 2024 Nektar Therapeutics Earnings Call

NKTR

Associated Press Finance

8 months ago

Nektar: Q1 Earnings Snapshot

Nektar Therapeutics Reports First Quarter 2024 Financial Results
NKTR

PR Newswire

8 months ago

Nektar Therapeutics Reports First Quarter 2024 Financial Results

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
NKTR

PR Newswire

9 months ago

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
NKTR

Zacks

10 months ago

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
NKTR

PR Newswire

10 months ago

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
NKTR

Zacks

a year ago

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
NKTR

Zacks

a year ago

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript
NKTR

Insider Monkey

a year ago

Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata
NKTR

PR Newswire

a year ago

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata

NKTR

Thomson Reuters StreetEvents

a year ago

Q4 2023 Nektar Therapeutics Earnings Call

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
NKTR

Zacks

a year ago

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results
NKTR

GuruFocus.com

a year ago

Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results

NKTR

Associated Press Finance

a year ago

Nektar: Q4 Earnings Snapshot

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
NKTR

PR Newswire

a year ago

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
NKTR

PR Newswire

a year ago

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
NKTR

PR Newswire

a year ago

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
NKTR

PR Newswire

a year ago

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets

Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
NKTR

Zacks

a year ago

Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know

Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans?
NKTR

Simply Wall St.

a year ago

Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans?

NKTR

GlobeNewswire

a year ago

RGC Resources Holds Annual Shareholders Meeting

NKTR

GlobeNewswire

a year ago

RGC Resources, Inc. Schedules First Quarter 2024 Earnings Call

NKTR

Business Wire

a year ago

ClearBridge MLP Funds Announce Proposed Mergers and Updates for Tender Offers

NKTR

Thomson Reuters StreetEvents

a year ago

Q4 2023 First Internet Bancorp Earnings Call

USCB Financial Holdings, Inc. Reports Diluted EPS of $0.14 for Q4 2023
NKTR

GlobeNewswire

a year ago

USCB Financial Holdings, Inc. Reports Diluted EPS of $0.14 for Q4 2023

First Internet (INBK) Reports Q4 Earnings: What Key Metrics Have to Say
NKTR

Zacks

a year ago

First Internet (INBK) Reports Q4 Earnings: What Key Metrics Have to Say

FAT Brands (FAT) Reports Solid Unit Developments in 2023
NKTR

Zacks

a year ago

FAT Brands (FAT) Reports Solid Unit Developments in 2023

Crexendo® Earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award for Excellence in Cloud Communications
NKTR

PR Newswire

a year ago

Crexendo® Earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award for Excellence in Cloud Communications

FAT Brands Sends Off 2023 With Another Year of Strong Organic Growth
NKTR

GlobeNewswire

a year ago

FAT Brands Sends Off 2023 With Another Year of Strong Organic Growth

NKTR

Business Wire

a year ago

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in December

D-Market Elektronik Hizmetler ve Ticaret A.S.'s (NASDAQ:HEPS) Stock Is Going Strong: Have Financials A Role To Play?
NKTR

Simply Wall St.

a year ago

D-Market Elektronik Hizmetler ve Ticaret A.S.'s (NASDAQ:HEPS) Stock Is Going Strong: Have Financials A Role To Play?

Pinstripes Holdings, Inc. Rings the NYSE Opening Bell Today and Reports Preliminary Unaudited Fiscal 2024 Third Quarter Sales Results
NKTR

Business Wire

a year ago

Pinstripes Holdings, Inc. Rings the NYSE Opening Bell Today and Reports Preliminary Unaudited Fiscal 2024 Third Quarter Sales Results

NKTR

Business Wire

a year ago

Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of February 2024

Hear from Dale Schwartz, Founder & CEO of Pinstripes Holdings Inc. Live at ICR Conference 2024
NKTR

IPO-Edge.com

a year ago

Hear from Dale Schwartz, Founder & CEO of Pinstripes Holdings Inc. Live at ICR Conference 2024

7 Cyclical Penny Stocks Best Positioned for 2024
NKTR

InvestorPlace

a year ago

7 Cyclical Penny Stocks Best Positioned for 2024

ESS Expands Deployment Footprint in California, Commissions New Project and Advances Energy Center Product Line
NKTR

Business Wire

a year ago

ESS Expands Deployment Footprint in California, Commissions New Project and Advances Energy Center Product Line

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony
NKTR

Business Wire

a year ago

Kopin Corporation Unveils New Era of Innovation and Leadership Following NASDAQ Closing Bell Ceremony

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location
NKTR

Zacks

a year ago

FAT Brands (FAT) Unveils First Co-Branded Los Angeles Location

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications
NKTR

Business Wire

a year ago

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications

Small Stocks, Massive Rewards: 3 Growth Picks with 1,000% Upside
NKTR

InvestorPlace

a year ago

Small Stocks, Massive Rewards: 3 Growth Picks with 1,000% Upside

BioCryst (BCRX) Moves 25.6% Higher: Will This Strength Last?
NKTR

Zacks

a year ago

BioCryst (BCRX) Moves 25.6% Higher: Will This Strength Last?

First Western Financial's (NASDAQ:MYFW) investors will be pleased with their respectable 43% return over the last five years
NKTR

Simply Wall St.

a year ago

First Western Financial's (NASDAQ:MYFW) investors will be pleased with their respectable 43% return over the last five years

CorMedix Inc. Announces Commercial and Operational Updates
NKTR

GlobeNewswire

a year ago

CorMedix Inc. Announces Commercial and Operational Updates

GrowGeneration Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR Conference
NKTR

Business Wire

a year ago

GrowGeneration Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR Conference

NKTR

Business Wire

a year ago

ClearBridge MLP and Midstream Total Return Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2023

RGC Resources, Inc.'s (NASDAQ:RGCO) largest shareholders are retail investors with 45% ownership, institutions own 36%
NKTR

Simply Wall St.

a year ago

RGC Resources, Inc.'s (NASDAQ:RGCO) largest shareholders are retail investors with 45% ownership, institutions own 36%

Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
NKTR

PR Newswire

a year ago

Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Lazard Global Total Return and Income Fund Announces Monthly Distribution Amount
NKTR

Business Wire

a year ago

Lazard Global Total Return and Income Fund Announces Monthly Distribution Amount

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NKTR

GlobeNewswire

a year ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners
NKTR

Simply Wall St.

a year ago

Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners

Share on Social Networks: